
The diabetes drug Invokana and other potentially faulty drugs can cause ketoacidosis, a buildup of acids in the blood that requires hospitalization to treat, according to a recent Food and Drug Administration warning. The FDA safety warning covers a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are marketed…